Simeon Pollack. 2011. “The Rationale for Using Hydroxycarbamide in the Treatment of Sickle Cell disease” (Haematologica 2011;96:488–491). Reply”. Haematologica 96 (6). Pavia, Italy, e30-e30. https://doi.org/10.3324/haematol.2011.046409.